Sky Century Investment (SKYI) Net Cash Flow (2012 - 2026)
Sky Century Investment (SKYI) posted quarterly Net Cash Flow of -$3096.0 for Q2 2026, down 127.37% year-over-year from $11312.0 in Q2 2025, and down 207.02% quarter-over-quarter from $2893.0 in Q1 2026.
Sky Century Investment (SKYI) Net Cash Flow (2012 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Net Cash Flow for 6 consecutive years, with -$3096.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Net Cash Flow fell 127.37% year-over-year to -$3096.0; the TTM figure through May 2026 stood at -$11048.0 (down 197.67% YoY), while the FY2025 annual figure was $477.0, changed N/A from the prior year.
- Net Cash Flow retreated to -$3096.0 in Q2 2026 per SKYI's latest filing, from $2893.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $11312.0 in Q2 2025 and bottomed at -$10835.0 in Q3 2025.
- Historically, Net Cash Flow has averaged -$1722.3 across 3 years, with a median of -$1553.0 in 2025.
- On a YoY basis, Net Cash Flow climbed as much as 127.37% in 2026 and fell as far as 127.37% in 2026.
- Sky Century Investment's Net Cash Flow stood at -$10598.0 in 2024, then soared by 99.91% to -$10.0 in 2025, then tumbled by 30860.0% to -$3096.0 in 2026.
- Business Quant data shows SKYI's Net Cash Flow at -$3096.0 in Q2 2026, $2893.0 in Q1 2026, and -$10.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | -3,096.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -3,096.00 |
| May 31, 2026 | -3,096.00 |
| Feb 28, 2026 | 2,893.00 |
| Feb 28, 2026 | 2,893.00 |
| Nov 30, 2025 | -10.00 |
| Nov 30, 2025 | -10.00 |
| Aug 31, 2025 | -10,835.00 |
| Aug 31, 2025 | -10,835.00 |
| May 31, 2025 | 11,312.00 |
| May 31, 2025 | 11,312.00 |
| Feb 29, 2024 | -10,598.00 |
| Feb 29, 2024 | -10,598.00 |
| Feb 28, 2014 | -5,050.00 |
| Feb 28, 2014 | -5,050.00 |
| Nov 30, 2013 | 5,086.00 |
| Nov 30, 2013 | 5,086.00 |
| Aug 31, 2013 | 325.00 |
| Aug 31, 2013 | 325.00 |
| Feb 28, 2013 | -200.00 |
| Feb 28, 2013 | -200.00 |